WHO recommends a second vaccine for malaria prevention 

In a major advancement for child health and malaria control, WHO has recommended a second vaccine to prevent malaria among children living in areas of risk. The addition of the R21/Matrix-M vaccine to complement the ongoing rollout of the first malaria vaccine, RTS,S/AS01, is expected to result in sufficient vaccine supply to benefit all children living in areas where malaria is a major public health problem. 

Press release  | Remarks by the WHO Director-General

Meeting report of the Technical Advisory Group on Malaria Elimination and Certification (TAG-MEC)

This report describes the outcomes of the first and second meetings of TAG-MEC, held in September 2022 and January 2023. It highlights findings of the independent evaluation missions to Azerbaijan and Tajikistan and the group’s recommendation that both countries be certified malaria-free.

Meeting report | Malaria-free certification of Azerbaijan and Tajikistan

Meeting report: Technical consultation to assess comparative efficacy of vector control products 

This report outlines the outcomes of a technical consultation held in June 2023 to assess the comparative efficacy of 3 insecticide-treated nets (DuraNet Plus©, Yorkool® G3, PermaNet® Dual) and 1 indoor residual surface treatment (VECTRON^TM T500) against the first-in-class product in their respective intervention classes.  

Meeting report

Translations

The following publication is now available in French:

• Chimioprévention du paludisme saisonnier par administration de sulfadoxine-pyriméthamine et d’amodiaquine aux enfants : guide de terrain (deuxième édition)